(Q44654976)

5 December 2017

title

Guidelines for the management of alopecia areata (English)

1 reference

5 December 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

British Association of Dermatologists

1 April 2024

author

6

object named as

British Association of Dermatologists

1 reference

5 December 2017

S. P. MacDonald Hull

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616359

1 April 2024

M. L. Wood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616359

1 April 2024

P. E. Hutchinson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616359

1 April 2024

M. Sladden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616359

1 April 2024

A. G. Messenger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616359

1 April 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

5 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2133.2003.05535.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2133.2003.05535.x/fullpdf

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

British Journal of Dermatology

1 April 2024

published in

1 reference

5 December 2017

volume

149

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

692-699

1 reference

Treatment of alopecia areata with steroid solution

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

Ocular complications of topical, peri-ocular, and systemic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

Prednisone therapy for alopecia areata. A follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

1-chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

Treatment of Alopecia Areata by Anthralin-Induced Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05535.X

A statistical study and consideration of endocrine influences

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

A New Classification of Alopecia Areata

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Alopecia areata: a clinical study.

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

The pathogenesis of alopecia areata

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

East African Medical Journal

1 April 2024

14

71

674

Kubeyinje EP.

1994

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Anaphylaxis to intradermal triamcinolone acetonide

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Pulse of methylprednisolone in alopecia areata.

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Pulsed administration of corticosteroids in the treatment of alopecia areata

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Proceedings: Epidermolysis bullosa

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Efficacy of topical sensitizers in the treatment of alopecia areata

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

1 April 2024

Archives of Dermatology

32

137

1063

Wiseman MC

2001

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Alopecia areata in children: response to treatment with diphencyprone.

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Contact urticaria during topical immunotherapy.

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Topical photochemotherapy for alopecia areata

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

An evaluation of PUVA-therapy for alopecia areata

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

PUVA treatment for alopecia areata--does it work? A retrospective review of 102 cases

1 April 2024

45

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Topical minoxidil in the treatment of alopecia areata.

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Extensive alopecia areata. Results of treatment with 3% topical minoxidil

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation.

1 April 2024

55

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Oral zinc sulphate in alopacia areata-a double blind trial

1 April 2024

56

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone

1 April 2024

57

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

Randomized trial of aromatherapy. Successful treatment for alopecia areata

1 April 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

1 April 2024

Wigs

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05535.X

1 April 2024

Identifiers

1 reference

5 December 2017

1 reference